Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fenvalerate-degrading enzymes from Enterobacter and Micrococcus species are microbial proteins, primarily carboxylesterases and hydrolases, that facilitate the breakdown of the synthetic pyrethroid insecticide fenvalerate (PubChem CID 3323). These enzymes play a critical role in environmental bioremediation by detoxifying pesticide residues in soil and water systems (Chen et al., 2011, Journal of Hazardous Materials). The biological function involves the cleavage of the ester linkage within the fenvalerate structure, converting the parent compound into smaller, typically less harmful metabolites like 3-phenoxybenzoic acid (3-PBA) (Tallur et al., 2008, Biodegradation). While not a therapeutic target for human disease, these enzymes are significant in the context of environmental health and toxicology. They are studied for their potential to mitigate the ecological impact of pyrethroid contamination and to understand the metabolic pathways of xenobiotics in microbial consortia. The efficiency of these enzymes is often enhanced when Enterobacter and Micrococcus species work in syntrophic association, allowing for more complete mineralization of the pesticide.
The enzymes catalyze the hydrolysis of the ester bond in the fenvalerate molecule, breaking it down into less toxic metabolites such as 3-phenoxybenzoic acid.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fenvalerate-degrading enzymes (Enterobacter spp. and Micrococcus spp.).